Patrick Baumhof
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- Viral gastroenteritis research and epidemiology
- Immunology top 5%
- Immunotherapy and Immune Responses
Papers in
-
- RNA Interference and Gene Delivery 9
- Advanced biosensing and bioanalysis techniques 2
- CRISPR and Genetic Engineering 2
- Genetics 5
- Virus-based gene therapy research 4
- Co-authors
- Mariola Fotin‐Mleczek (5 shared papers)Barbara L. Mui (3 shared papers)Michael J. Hope (3 shared papers)Andreas Theß (3 shared papers)Thomas Schlake (3 shared papers)Stefanie Grund (2 shared papers)Regina Heidenreich (3 shared papers)Margit Schnee (2 shared papers)
- Journals
- Molecular Therapy — Nucleic Acids (2 papers)Molecular Therapy (2 papers)Nature Biomedical Engineering (1 paper)Plasma Processes and Polymers (1 paper)Nano Letters (1 paper)
- Partner nations
- GermanyUnited StatesNew Zealand
In The Last Decade
Patrick Baumhof
14 papers receiving 1.3k citations
Patrick Baumhof's Hit Papers
Peers
Comparison fields: 5 of 82
- Infectious Diseases 430
- Immunology 472
- Virology 89
- Molecular Biology 984
- Animal Science and Zoology 118
Countries citing papers authored by Patrick Baumhof
This map shows the geographic impact of Patrick Baumhof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Baumhof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Baumhof more than expected).
Fields of papers citing papers by Patrick Baumhof
This network shows the impact of papers produced by Patrick Baumhof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Baumhof. The network helps show where Patrick Baumhof may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick Baumhof, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals Hit paper breakdown → | 2015 | 414 |
| 2 | 2017 | 207 | |
| 3 | 2013 | 186 | |
| 4 | 2016 | 166 | |
| 5 | 2019 | 149 | |
| 6 | 2016 | 85 | |
| 7 | 2010 | 59 | |
| 8 | 2022 | 28 | |
| 9 | 2018 | 20 | |
| 10 | 2007 | 17 | |
| 11 | 2018 | 16 | |
| 12 | 2015 | 7 | |
| 13 | 2024 | 6 | |
| 14 | 2025 | 3 |
About Patrick Baumhof
Patrick Baumhof is a scholar working on Molecular Biology, Genetics, Immunology, Infectious Diseases and Virology, having authored 14 papers that have together received 1.4k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (9 papers), Virus-based gene therapy research (4 papers), Immunotherapy and Immune Responses (3 papers), Immune Response and Inflammation (3 papers), Advanced biosensing and bioanalysis techniques (2 papers), CRISPR and Genetic Engineering (2 papers), Poxvirus research and outbreaks (1 paper) and Metal and Thin Film Mechanics (1 paper). The work is most often cited by research in Infectious Diseases (430 citations), Immunology (472 citations), Virology (89 citations), Molecular Biology (984 citations) and Animal Science and Zoology (118 citations). Patrick Baumhof has collaborated with scholars based in Germany, United States and New Zealand. Frequent co-authors include Mariola Fotin‐Mleczek, Barbara L. Mui, Michael J. Hope, Andreas Theß, Thomas Schlake, Stefanie Grund, Regina Heidenreich, Margit Schnee, Benjamin Petsch and Annette B. Vogel. Their work appears in journals such as Molecular Therapy — Nucleic Acids, Molecular Therapy, Nature Biomedical Engineering, Plasma Processes and Polymers and Nano Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.